Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men
Public ClinicalTrials.gov record NCT02236988. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Open-Label, Single Center Study to Evaluate the Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast (CC-10004) in Healthy Male Subjects
Study identification
- NCT ID
- NCT02236988
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- Apremilast Immediate Release Drug
- Apremilast Modified Release 1 Drug
- Apremilast Modified Release 2 Drug
- Apremilast Modified Release 3 Drug
- Apremilast Modified Release 4 Drug
- Apremilast Modified Release 5 Drug
- Apremilast Modified Release 6 Drug
- Apremilast Modified Release 8 Drug
- Apremilast Modified Release 9 Drug
- Apremilast Modified Release 11 Drug
- Apremilast Modified Release 12 Drug
- Apremilast Modified Release 13 Drug
- Apremilast Modified Release 14 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 6, 2014
- Primary completion
- Sep 10, 2014
- Completion
- Sep 10, 2014
- Last update posted
- May 31, 2021
2014
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Covance Clinical Research Unit Inc. | Madison | Wisconsin | 53704-2526 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02236988, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2021 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02236988 live on ClinicalTrials.gov.